Name: Tubastatin A Hydrochloride
Brand: Selleck Chemicals
SKU: S2627
Rating: 5 (47 reviews)

Hoppa till

Kvalitetskontroll (Quality Control)

Batch: Renhet: 99.38%

99.38

Relaterade mål	JAK BET Histone Methyltransferase PKC PARP HIF PRMT EZH2 AMPK Sirtuin
Övrigt HDAC Inhibitorer	ITF-2357 (Givinostat) Hydrochloride Monohydrate Fimepinostat (CUDC-907) Trichostatin A (TSA) Entinostat (MS-275) RGFP966 Quisinostat (JNJ-26481585) Dihydrochloride Tubastatin A Mocetinostat (MGCD0103) Ricolinostat (ACY-1215) PCI-34051

Cellodling, behandling & arbetskoncentration
(Cell Culture, Treatment & Working Concentration)

Cellinjer	Analystyp	Koncentration	Formulering	Aktivitetsbeskrivning
neuron cultures	Kinase assay	2.5 μM	DMSO	induces α-tubulin hyperacetylation
neuron cultures	Function assay	~10 μM	DMSO	protects against glutathione depletion-induced oxidative stress
134/04	Function assay	7.5 µM		impairs myotube formation
C2C12	Function assay	7.5 µM		impairs myotube formation
HaCaT keratinocytes	Function assay	10 μM		blocks arsenite from inducing Nrf2 protein translation
JURL-MK1	Function assay	10 μM		enhances cell adhesivity to fibronectin
CML-T1	Function assay	10 μM		enhances cell adhesivity to fibronectin
K562	Function assay	10 μM		enhances cell adhesivity to fibronectin
HL-60	Function assay	10 μM		enhances cell adhesivity to fibronectin
KMCH	Growth inhibitory assay	~10 μM		decreases proliferation and anchorage-independent growth
THP-1	Function assay	~10 μM		inhibits TNF-α and IL-6 secretion
RAW 264.7	Function assay	~10 μM		attenuates NO production
HT3	Function assay	~5 μM	DMSO	induces the differential α-tubulin acetylation
SiHa	Function assay	~5 μM	DMSO	induces the differential α-tubulin acetylation
CaSki	Function assay	~5 μM	DMSO	induces the differential α-tubulin acetylation
SiHa	Function assay	~5 μM	DMSO	inhibits Thapsigargin- or EGF-induced SOCE activation
CaSki	Function assay	~5 μM	DMSO	inhibits Thapsigargin- or EGF-induced SOCE activation
MCF-7	Growth inhibitory assay	30 μM	DMSO	IC50=15 μM
MCF-7	Function assay	30 μM	DMSO	increases the microtubule acetylation level.
MCF-7	Function assay	30 μM	DMSO	stabilizes microtubules against cold-induced depolymerization
MCF-7	Function assay	15 μM	DMSO	stabilizes microtubules against nocodazole-induced disassembly
MCF-7	Function assay	30 μM	DMSO	alteres the assembly dynamics of interphase microtubules
MCF-7	Function assay	30 μM	DMSO	increases the binding of HDAC6 with interphase microtubules
PC12	Function assay	~3 μM	DMSO	up-regulates anti-oxidative gene expression related to transcription factor XBP1s
PC12	Growth inhibitory assay	~3 μM	DMSO	reverse H2O2-induced growth inhibition
HEK293T	Function assay	~3 μM	DMSO	up-regulated XBP1s protein level
HEK293T	Function assay	~3 μM	DMSO	delays XBP1s protein degradation via acetylation-mediated proteasomal degradation
Huh7	Function assay	~5 μM	DMSO	suppresses proliferation of hepatitis C virus replicon with EC50 = 0.3 μM
SKMEL21	Growth inhibitory assay	~500 nM	DMSO	inhibits cell proliferation
SKMEL103	Growth inhibitory assay	~500 nM	DMSO	inhibits cell proliferation
SKMEL28	Growth inhibitory assay	~500 nM	DMSO	inhibits cell proliferation
WM164	Growth inhibitory assay	~500 nM	DMSO	inhibits cell proliferation
WM1361a	Growth inhibitory assay	~500 nM	DMSO	inhibits cell proliferation
WM1366	Growth inhibitory assay	~500 nM	DMSO	inhibits cell proliferation
WM793	Growth inhibitory assay	~500 nM	DMSO	inhibits cell proliferation
WM35	Growth inhibitory assay	~500 nM	DMSO	inhibits cell proliferation
WM983a	Growth inhibitory assay	~500 nM	DMSO	inhibits cell proliferation
WM793	Function assay	~6 μM	DMSO	induce G1 arrest
WM164	Function assay	~6 μM	DMSO	induce G1 arrest
WM983a	Function assay	~6 μM	DMSO	induce G1 arrest
WM164	Function assay	~3 μM	DMSO	augments expression of MHC class I and melanoma associated antigens
WM983a	Function assay	~3 μM	DMSO	augments expression of MHC class I and melanoma associated antigens
IPC298	Function assay	~3 μM	DMSO	augments expression of MHC class I and melanoma associated antigens
SKMEL30	Function assay	~3 μM	DMSO	augments expression of MHC class I and melanoma associated antigens
TCa83	Function assay			induces PTEN expression and membrane translocation
293T	Function assay	~2 μg/ml		induces PTEN expression and membrane translocation
SACC-83	Function assay	~2 μg/ml		induces PTEN expression and membrane translocation
293T	Function assay	~2 μg/ml		induces PTEN acetylation at K163
U-87 MG	Function assay	~2 μg/ml		inhibits the migration and invasion
U-87 MG	Function assay	~10 μM		inhibits AKT phosphorylation
U-87 MG	Growth inhibitory assay	~10 μM		inhibits cell growth
Klicka för att visa mer experimentella data för cellinjer

Kemisk information, lagring & stabilitet (Chemical Information, Storage & Stability)

Molekylvikt	371.86	Formel	C₂₀H₂₁N₃O₂.HCl	Lagring (från mottagningsdatumet)	3 år-20°Cpulver
CAS-nr	1310693-92-5	Ladda ner SDF		Lagring av stamlösningar	1 år-80°Ci lösningsmedel 1 månad-20°Ci lösningsmedel

Löslighet (Solubility)

In vitro
Batch:

DMSO : 74 mg/mL (198.99 mM)
(Fuktkontaminerad DMSO kan minska lösligheten. Använd färk, vattenfri DMSO.)

Water : Insoluble

Ethanol : Insoluble

DMSO : 100 mg/mL (268.91 mM) Uppvärmd med 60°C vattenbad; Ultraljudsbehandlad;
(Fuktkontaminerad DMSO kan minska lösligheten. Använd färk, vattenfri DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molaritetsräknare

Massa	Koncentration	Volym	Molekylvikt
=	×	×

Utspädningsräknare Molekylviktsräknare

In vivo Batch:
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution	5%DMSO 1 40%PEG300 2 5%Tween80 3 50%ddH2O Validerad av Selleck-laboratorier. Om du behöver justeringar av denna formulering, kontakta vårt säljteam för skräddarsydd testning.	5.000mg/ml (13.45mM)	Taking the 1 mL working solution as an example, add 50 μL of 100 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution	5%DMSO 1 40%PEG300 2 5%Tween80 3 50%ddH2O Validerad av Selleck-laboratorier. Om du behöver justeringar av denna formulering, kontakta vårt säljteam för skräddarsydd testning.	1.000mg/ml (2.69mM)	Taking the 1 mL working solution as an example, add 50 μL of 20 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results.

In vivo-formuleringsräknare (Klar lösning)

Steg 1: Ange information nedan (Rekommenderas: Ett extra djur för att ta hänsyn till förluster under experimentet)

Dosering: mg/kg Djurens medelvikt: g Doseringsvolym per djur:μL Antal djur:

Steg 2: Ange in vivo-formuleringen (Detta är endast räknaren, inte formuleringen. Vänligen kontakta oss först om det inte finns någon in vivo-formulering i löslighetsavsnittet.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Beräkningsresultat:

Arbetskoncentration: mg/ml;

Metod för att bereda DMSO-stamlösning: mg substans förlöst i μL DMSO ( Stamlösningskoncentration mg/mL, Vänligen kontakta oss först om koncentrationen överskrider DMSO-lösligheten för denna batch av substansen. )

Metod för att bereda in vivo-formulering: Ta μL DMSO stamlösning, tillsätt sedanμL PEG300, blanda och klarna, tillsätt sedanμL Tween 80, blanda och klarna, tillsätt sedan μL ddH₂O, blanda och klarna.

Metod för att bereda in vivo-formulering: Ta μL DMSO stamlösning, tillsätt sedan μL Majsolja, blanda och klarna.

Obs: 1. Se till att vätskan är klar innan du tillsätter nästa lösningsmedel.
2. Se till att tillsätta lösningsmedlet/lösningsmedlen i ordning. Du måste se till att lösningen som erhålls i föregående tillsats är en klar lösning innan du fortsätter att tillsätta nästa lösningsmedel. Fysiska metoder som vortex, ultraljud eller varmt vattenbad kan användas för att underlätta upplösningen.

Verkningsmekanism (Mechanism of Action)

Targets/IC₅₀/Ki	HDAC6 (Cell-free assay) 15 nM HDAC8 (Cell-free assay) 854 nM
In vitro	Tubastatin A is substantially selective for all 11 HDAC isoforms and maintains over 1000-fold selectivity against all isoforms excluding HDAC8, where it has approximately 57-fold selectivity. In homocysteic acid (HCA) induced neurodegeneration assays, Tubastatin A displays dose-dependent protection against HCA-induced neuronal cell death starting at 5 μM with near complete protection at 10 μM. At 100 ng/mL Tubastatin A increases Foxp3+ T-regulatory cells (Tregs) suppression of T cell proliferation in vitro. Tubastatin A treatment in C2C12 cells would lead to myotube formation impairment when alpha-tubulin is hyperacetylated early in the myogenic process; however, myotube elongation occurs when alpha-tubulin is hyeperacetylated in myotubes. A recent study indicates that Tubastatin A treatment increases cell elasticity as revealed by atomic force microscopy (AFM) tests without exerting drastic changes to the actin microfilament or microtubule networks in mouse ovarian cancer cell lines, MOSE-E and MOSE-L.
Kinasanalys	Enzyminhibitionsanalyser
Kinasanalys	Enzyminhibitionsanalyser utförs av Reaction Biology Corporation, Malvern, PA, med hjälp av Reaction Biology HDAC Spectrum-plattformen. (www.reactionbiology.com) HDAC1-, 2-, 4-, 5-, 6-, 7-, 8-, 9-, 10- och 11-analyserna använder isolerat rekombinant humant protein; HDAC3/NcoR2-komplexet används för HDAC3-analysen. Substratet för HDAC1, 2, 3, 6, 10 och 11-analyserna är en fluorogen peptid från p53-rester 379-382 (RHKKAc); substratet för HDAC8 är en fluorogen diacylpeptid baserad på rester 379-382 av p53 (RHKAcKAc). Acetyl-Lys (trifluoracetyl)-AMC-substrat används för HDAC4, 5, 7 och 9-analyserna. Tubastatin A löses i DMSO och testas i 10-dos IC50-läge med 3-faldig seriell utspädning med början vid 30 μM. Kontrollföreningen Trichostatin A (TSA) testas i en 10-dos IC50 med 3-faldig seriell utspädning med början vid 5 μM. IC50-värden extraheras genom kurvanpassning av dos/respons-lutningarna.
In vivo	Daily treatment of Tubastatin A at 0.5mg/kg inhibits HDAC6 to promote Tregs suppressive activity in mouse models of inflammation and autoimmunity, including multiple forms of experimental colitis and fully major histocompatibility complex (MHC)-incompatible cardiac allograft rejection.
Referenser	[1] https://pubmed.ncbi.nlm.nih.gov/20614936/ [2] https://pubmed.ncbi.nlm.nih.gov/21444725/ [3] https://pubmed.ncbi.nlm.nih.gov/22174839/ [4] https://pubmed.ncbi.nlm.nih.gov/22446682/

Applikationer (Applications)

Metoder	Biomarkörer	Bilder	PMID
Western blot	EGFR / p-AKT / AKT / p-ERK / ERK		29665050
Immunofluorescence	α-tubulin / Acetylated tubulin HDAC6		23798680

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

Tubastatin A Hydrochloride HDAC6-hämmare

Molekylvikt: 371.86

Kvalitetskontroll (Quality Control)

Cellodling, behandling & arbetskoncentration
(Cell Culture, Treatment & Working Concentration)

Kemisk information, lagring & stabilitet (Chemical Information, Storage & Stability)

Löslighet (Solubility)

Molaritetsräknare

In vivo-formuleringsräknare (Klar lösning)

Verkningsmekanism (Mechanism of Action)

Applikationer (Applications)

Tubastatin A Hydrochloride HDAC6-hämmare

Molekylvikt: 371.86

Kvalitetskontroll (Quality Control)

Cellodling, behandling & arbetskoncentration (Cell Culture, Treatment & Working Concentration)

Kemisk information, lagring & stabilitet (Chemical Information, Storage & Stability)

Löslighet (Solubility)

Molaritetsräknare

In vivo-formuleringsräknare (Klar lösning)

Verkningsmekanism (Mechanism of Action)

Applikationer (Applications)

Cellodling, behandling & arbetskoncentration
(Cell Culture, Treatment & Working Concentration)